Seres Therapeutics, Inc. ($MCRB)
Henn Matthew R โ President and Chief Scientific Officer
Shares
75,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Mar 12, 2026
EPS:-1.89 (est: -2.11)-10.4%
Revenue:$438.00K
Transaction Details
| Insider | Henn Matthew R |
|---|---|
| Title | President and Chief Scientific Officer |
| Transaction Date | Mar 4, 2026 |
| Expiration Date | Mar 3, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Purchased | 75,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 75,000 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-096700 |
| Document | View SEC Filing |